ID

34584

Description

A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01057628

Link

https://clinicaltrials.gov/show/NCT01057628

Keywords

  1. 1/19/19 1/19/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 19, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Type 2 Diabetes Mellitus NCT01057628

Eligibility Type 2 Diabetes Mellitus NCT01057628

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetic patients for at least 12 weeks
Description

ID.1

Data type

boolean

hba1c value between 7.0 and 10.0%
Description

ID.2

Data type

boolean

body mass index (bmi) 20.0 - 45.0 kg/m2
Description

ID.3

Data type

boolean

investigator adjudicates that a subject is able to discontinue currently taking hypoglycemic agents safely during treatment
Description

ID.4

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
type 1 diabetes mellitus patients
Description

ID.5

Data type

boolean

serum creatinine > upper limit of normal
Description

ID.6

Data type

boolean

proteinuria (albumin/creatinine ratio > 300mg/g)
Description

ID.7

Data type

boolean

dysuria and/or urinary tract infection, genital infection
Description

ID.8

Data type

boolean

significant renal, hepatic or cardiovascular diseases
Description

ID.9

Data type

boolean

severe gastrointestinal diseases
Description

ID.10

Data type

boolean

Similar models

Eligibility Type 2 Diabetes Mellitus NCT01057628

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
type 2 diabetic patients for at least 12 weeks
boolean
ID.2
Item
hba1c value between 7.0 and 10.0%
boolean
ID.3
Item
body mass index (bmi) 20.0 - 45.0 kg/m2
boolean
ID.4
Item
investigator adjudicates that a subject is able to discontinue currently taking hypoglycemic agents safely during treatment
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
type 1 diabetes mellitus patients
boolean
ID.6
Item
serum creatinine > upper limit of normal
boolean
ID.7
Item
proteinuria (albumin/creatinine ratio > 300mg/g)
boolean
ID.8
Item
dysuria and/or urinary tract infection, genital infection
boolean
ID.9
Item
significant renal, hepatic or cardiovascular diseases
boolean
ID.10
Item
severe gastrointestinal diseases
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial